The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

The Sputum AFB Test detects acid-fast bacilli in sputum, indicating a tuberculosis infection.

Provide sputum samples early in the morning in a sterile container. Avoid substances that might alter sputum consistency.

Results are typically available within 7 to 10 days due to the time needed for culturing and analysis.

It is essential for diagnosing tuberculosis, monitoring treatment progress, and preventing the spread of TB.

Book online through our website or contact our customer service team at Chirayu SuperSpeciality Hospital.

High CPK-MB levels typically indicate heart muscle damage, such as from a heart attack.

Yes, certain medications can influence CPK-MB levels. It’s important to inform your healthcare provider about all medications you are taking.

No, fasting is not required for the CPK-MB test unless specified by your healthcare provider.

The frequency of testing depends on your health condition and your healthcare provider’s recommendations.

Abnormal CPK-MB levels may indicate heart muscle damage. Further evaluation and treatment will be necessary based on your test results.